Compare AMP & A Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AMP | A |
|---|---|---|
| Founded | 1894 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 48.1B | 39.8B |
| IPO Year | 2008 | 1999 |
| Metric | AMP | A |
|---|---|---|
| Price | $466.89 | $118.92 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 16 |
| Target Price | ★ $560.20 | $162.31 |
| AVG Volume (30 Days) | 716.8K | ★ 2.2M |
| Earning Date | 04-30-2026 | 05-27-2026 |
| Dividend Yield | ★ 1.35% | 0.86% |
| EPS Growth | ★ 9.77 | 3.16 |
| EPS | ★ 36.28 | 4.57 |
| Revenue | ★ $18,911,000,000.00 | $4,472,000,000.00 |
| Revenue This Year | $1.71 | $8.03 |
| Revenue Next Year | $4.38 | $6.22 |
| P/E Ratio | ★ $13.14 | $25.82 |
| Revenue Growth | 5.49 | ★ 6.43 |
| 52 Week Low | $396.14 | $96.43 |
| 52 Week High | $550.18 | $160.27 |
| Indicator | AMP | A |
|---|---|---|
| Relative Strength Index (RSI) | 41.58 | 31.10 |
| Support Level | $463.00 | $110.49 |
| Resistance Level | $515.17 | $123.79 |
| Average True Range (ATR) | 16.43 | 3.73 |
| MACD | -1.51 | -0.30 |
| Stochastic Oscillator | 26.63 | 29.10 |
Ameriprise Financial has evolved into a diversified financial services provider that generates roughly 65% of its operating income from advice and wealth management. With nearly $1.2 trillion in segment assets under management and advisory at year-end 2025, and with roughly 10,600 affiliated and employee advisors, Ameriprise is one of the larger US-based wealth managers. It also boasts a reasonably large asset management franchise in Columbia Threadneedle, which boasted $678 billion in assets under management at year-end 2025. The firm's third key segment is its retirement and protection services business, which sells insurance products to the firm's advisory clients. After eliminations, Ameriprise had $1.69 trillion in assets under management and advisory across segments at year-end 2025.
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab consisting of consumables and services related to life science and applied tools, and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.